Urology Devices Market Trends Analysis, Growth Estimation, Future Dynamics, COVID-19 Impact, Size Projection By 2023

Urology Devices Market Overview:

The global report on the urology devices market is slated to make an impact with a 7.1% CAGR during the forecast period of 2018 to 2023. Market Research Future (MRFR) digs deep into the market to understand how different factors are impacting the market. One of the major driving forces is the increasing geriatric population. People belonging to this group are more susceptible to urological diseases and their rising number is expected to boost the urology devices market. Among others, the inclusion of advanced technologies and ease of funding are expected to inspire the market. The COVID-19 crisis also has some positive influence on the market.

Urology Devices Market Segmentation:

The global urology devices market has been segmented on the basis of applications, types, end users, and technology. These segments and their inputs are expected to help in developing strategies for the coming years.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/1120

By types, the study on the urology devices market comprises segments like urinary stone treatment devices, dialysis equipment, urinary incontinence & pelvic organ prolapsed devices, benign prostatic hyperplasia treatment devices, endoscopy devices, and others. The dialysis equipment segment includes haemodialysis, peritoneal dialysis, and others. The urinary stone treatment devices segment has been discussed on the basis of lithotripsy, ureteral stents, and others. The urinary incontinence & pelvic organ prolapsed devices have been segmented into vaginal meshes & slings, urethral inserts & pessaries, sacral neuromodulator, and others. The benign prostatic hyperplasia treatment devices segment includes catheter ablation, prostatic stents, and others.

By technology, the understanding of the market depends on a segmentation that includes robotic surgery, minimally invasive surgery, and others.

By applications, the study of the global urology devices market includes prostate cancer, benign prostatic hyperplasia, urinary incontinence, urinary stones, and others.

By end users, the global report containing the urology devices market comprises segments like ambulatory services, hospitals, and others. The hospital segment is expected to impact more due to the structural benefits and steady funding.

Urology Devices Market Regional Analysis:

The American urology devices market is expected to inspire changes. This is because the market gains significant support from the regional infrastructure and investment capacity. The US and Canada play a major role in transforming regional growth. In Asia Pacific, the market would witness substantial changes in the coming days.

Urology Devices Market Competitive Landscape:

Olympus Corporation (Japan), KARL STORZ GmbH & Co. KG (Germany), Boston Scientific Corporation (US), Medtronic (US), Fresenius Medical Care AG & Co. KGaA (Germany), C. R. Bard, Inc. (US), Cook (US), HealthTronics, Inc (US), Stryker (US), NIKKISO CO. LTD (Japan), Dornier MedTech (Germany), and others are some of the major companies impacting the global market in several ways. These companies mostly impact the urology devices market with strategic changes like merge, innovation, product launch, branding, and others.

Urology Devices Industry News:

Lumenis Ltd., known as the world’s largest energy-based medical device company that has plans for aesthetic, surgical and ophthalmic applications, announced the launch of MOSES 2.0. This is the next generation of the MOSES platform that is known for redefining urology care. MOSES 2.0 is a development of the MOSES technology platform, which guarantees its quality and help in pushing the boundaries to influence procedure efficiency, outcomes, and economics.

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/urology-devices-market-1120

Cipla Limited, an Indian pharmaceutical company, announced that it received approval from the United States Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Icatibant Injectable 30mg/3ml. This is a generic version of AP-rated Shire’s Firazyr and is effective in the treatment of acute attacks of hereditary angioedema (HAE).

Browse More Healthcare Related Research Report at:

Patient Engagement Solutions Market Research Report - Global Forecast till 2025
https://www.marketresearchfuture.com/reports/patient-engagement-solutions-market-8373

Gene Therapy Market Research Report - Global Forecast till 2025
https://www.marketresearchfuture.com/reports/gene-therapy-market-8399

Global Life Science Analytics Market Research Report—Forecast till 2025
https://www.marketresearchfuture.com/reports/life-science-analytics-market-8570

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

This release was published on openPR.